Learn

The complex management of antiviral treatment in patients with multiple comorbidities may be challenging. Join Dr Andrew Nguyen as he discusses COVID-19 antiviral drug-drug interactions.

Learning Outcomes

1. Evaluate clinical evidence to support the use of COVID-19 antivirals in eligible patients
2. Understand the management of drug-drug interactions with COVID-19 antivirals to support clinical decision making
3. Analyse relevant clinical cases and issues relating to the safe and effective use of COVID-19 antivirals.

Details

Author: Dr Andrew Nguyen MBBS FRACP BSc MSc

Article Type: Medical Education

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering the Pfizer myCPDhub portal. If you choose to register for this learning, you agree to provide some personal information directly to Pfizer. If you have any queries about how Pfizer collects, uses, discloses or stores your personal information, you should firstly consult their privacy policy available at www.pfizer.com.au. If you have any questions about Pfizer’s approach to privacy, please contact their Privacy Officer by email privacyofficer.anz@pfizer.com